Chelmsford Shoppers Drug Mart to be sold in Loblaw deal

As Loblaw continues its process to purchase Shoppers Drug Mart Corp., the Competition Bureau says it must sell certain locations where it will own too many stores in one area.
Loblaw Companies Ltd. has received approval from the Competition Bureau for its $12.4-billion purchase of Shoppers Drug Mart Corp., with a few stipulations. The government agency says Loblaw will be required to sell 18 stores and nine pharmacies that operate inside Loblaw stores to an independent operator. One of those stores is located in Chelmsford, near Sudbury, Ont. (Google Streetview)

As Loblaw continues its process to purchase Shoppers Drug Mart Corp., the Competition Bureau says it must sell certain locations where it will own too many stores in one area.

One of those stores set to be sold is the Shoppers Drug Mart in Chelmsford in Greater Sudbury.

Shoppers Drug Mart spokesperson Tammy Smitham said arrangements are being made as to what will happen with customers’ files at the pharmacy under a new owner.

"So their file would be transferred to the new owner of the location,” she said.

“Throughout the process they can expect to get the same level of quality and service that they've expected through the pharmacy there. They're not required to transfer their prescriptions but, if they wish to do so, they can also contact their pharmacist directly and arrange for that."

Loblaw will sell a total of 27 stores across Canada, and the process will take several months Smitham said.

Comments

To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.